balance equationreview2022-09-30
Difference 277000000 exceeds tolerance 144209000.000. Presentation or filing-vintage differences need review.
Revenue
$71.67B
Fiscal year ended 2026-06-30Net income
$1.66B
Fiscal year ended 2026-06-30Total assets
$157.08B
Fiscal year ended 2026-06-30Cigna Group (CI) reported revenue of $71.67B and net income of $1.66B for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Cigna Group’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Hospital & Medical Service Plans.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B | $63.69B | $60.52B | $57.26B |
| Cost of revenue | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B | $47.56B | $44.49B | $41.43B |
| Gross profit | $14.96B | $14.39B | $14.68B | $14.22B | $13.91B | $17.10B | $16.63B | $16.13B | $16.03B | $15.82B |
| Operating income | $2.68B | $2.36B | $2.34B | $2.58B | $2.31B | $1.97B | $2.17B | $2.58B | $2.41B | $2.26B |
| Net income | $1.66B | $1.65B | Unavailable | Unavailable | $1.53B | $1.32B | Unavailable | Unavailable | Unavailable | Unavailable |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 263.96M | shares 264.02M | -shares 964.00K | shares 267.53M | shares 268.15M | shares 272.95M | -shares 1.82M | shares 281.40M | shares 284.05M | shares 286.46M |
| Pretax income | $2.26B | $2.27B | $1.82B | $2.30B | $2.02B | $1.65B | $2.01B | $1.19B | $1.99B | $79.00M |
| Income tax expense | $382.00M | $409.00M | $543.00M | $322.00M | $389.00M | $239.00M | $473.00M | $367.00M | $360.00M | $291.00M |
| Diluted EPS | $6.29 | $6.26 | $4.66 | $6.98 | $5.71 | $4.85 | $5.07 | $2.63 | $5.45 | $-0.97 |
| Selling, general & administrative | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.86B | $3.59B | $3.68B | $3.70B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $6.30B | $7.04B | $7.68B | $6.02B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B |
| Total assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B |
| Current assets | $46.99B | $43.03B | $47.81B | $46.74B | $44.72B | $43.56B | $48.87B | $49.22B | $46.22B | $43.36B |
| Total liabilities | $114.17B | $110.82B | $116.04B | $115.90B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B |
| Current liabilities | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B | $57.06B | $55.37B | $51.98B |
| Total equity incl. NCI | $42.91B | $42.44B | $41.87B | $42.01B | $40.43B | $40.41B | $41.24B | $42.30B | $41.53B | $41.35B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $0 | $0 | $0 |
| Inventory | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B | $4.63B |
| Accounts receivable | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B | $27.85B | $25.11B | $20.56B |
| Goodwill | $45.53B | $45.53B | $44.92B | $44.92B | $44.38B | $44.37B | $44.37B | $44.37B | $44.26B | $44.26B |
| Long-term debt | $29.09B | $29.37B | $30.87B | $30.95B | $26.48B | $26.46B | $28.94B | $30.23B | $30.18B | $31.05B |
| Accounts payable | $10.41B | $9.88B | $10.66B | $9.35B | $9.94B | $9.14B | $9.29B | $8.52B | $9.28B | $8.12B |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$421.00M | $1.13B | $6.15B | $3.42B | -$1.89B | $1.92B | $5.21B | $46.00M | $265.00M | $4.84B |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$503.00M | -$637.00M | -$420.00M | -$4.39B | -$797.00M | $1.20B | -$191.00M | -$776.00M | -$640.00M | -$495.00M |
| Financing cash flow | $207.00M | -$1.14B | -$4.07B | $2.66B | -$1.33B | -$3.68B | -$3.25B | $439.00M | -$2.31B | -$2.53B |
| Net change in cash | -$724.00M | -$656.00M | $1.66B | $1.68B | -$3.99B | -$555.00M | $1.75B | -$273.00M | -$2.69B | $1.81B |
| Stock-based compensation | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common dividends paid | $409.00M | $417.00M | $396.00M | $402.00M | $401.00M | $412.00M | $384.00M | $390.00M | $392.00M | $401.00M |
| Common share repurchases | $280.00M | $0 | $1.00B | $0 | $1.11B | $1.51B | $2.02B | $0 | $990.00M | $4.02B |
| Depreciation & amortization | $655.00M | $650.00M | $722.00M | $697.00M | $682.00M | $674.00M | $646.00M | $650.00M | $738.00M | $741.00M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 20.9% | 21.0% | 20.3% | 20.4% | 20.7% | 26.1% | 25.3% | 25.3% | 26.5% | 27.6% |
| Operating margin | 3.7% | 3.4% | 3.2% | 3.7% | 3.4% | 3.0% | 3.3% | 4.0% | 4.0% | 3.9% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current ratio | 0.85x | 0.82x | 0.85x | 0.83x | 0.79x | 0.78x | 0.84x | 0.86x | 0.83x | 0.83x |
| Revenue YoY growth | 6.7% | 4.6% | 10.4% | 9.5% | 11.0% | 14.4% | 28.4% | 29.9% | 24.6% | 23.1% |
| Net margin | 2.3% | 2.4% | Unavailable | Unavailable | 2.3% | 2.0% | Unavailable | Unavailable | Unavailable | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.68x | Unavailable | 0.74x | 0.74x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 16.9% | 18.0% | 29.9% | 14.0% | 19.2% | 14.5% | 23.5% | 30.8% | 18.1% | 368.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CI in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-05-02View SEC filing
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.